Low-dose naltrexone for multiple sclerosis and autism: does its benefit reveal a common cause?

Med Hypotheses. 2006;67(3):671-2. doi: 10.1016/j.mehy.2006.04.015. Epub 2006 Jun 8.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anti-Inflammatory Agents / pharmacology
  • Autistic Disorder / drug therapy*
  • Autistic Disorder / etiology*
  • Autistic Disorder / immunology
  • Dose-Response Relationship, Drug
  • Humans
  • Models, Biological
  • Multiple Sclerosis / drug therapy*
  • Multiple Sclerosis / etiology*
  • Multiple Sclerosis / immunology
  • Naltrexone / pharmacology*
  • Naltrexone / therapeutic use
  • Narcotic Antagonists / pharmacology*
  • Narcotic Antagonists / therapeutic use
  • Nitric Oxide Synthase Type II / metabolism

Substances

  • Anti-Inflammatory Agents
  • Narcotic Antagonists
  • Naltrexone
  • Nitric Oxide Synthase Type II